Efficient Inhibition of Ovarian Cancer by Truncation Mutant of FILIP1L Gene Delivered by Novel Biodegradable Cationic Heparin-Polyethyleneimine Nanogels

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Human Gene Therapy

• Publication date

  2011-04-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/hum.2011.047PMID 21513424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Statistics, 2010

  2010cited by this paper
• Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer

  2010cited by this paper
• Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine.

  2010cited by this paper
• Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure.

  2010cited by this paper
• A ligand-mediated nanovector for targeted gene delivery and transfection in cancer cells.

  2009cited by this paper
• Functional characterization of filamin a interacting protein 1-like, a novel candidate for antivascular cancer therapy.

  2008cited by this paper
• Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: In vitro characteristics and transfection efficiency.

  2008cited by this paper
• HMGA2 gene is a promising target for ovarian cancer silencing therapy

  2008cited by this paper
• Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

  2008cited by this paper
• Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example.

  2008cited by this paper
• Dynamic progression of an intraperitoneal xenograft model of human ovarian cancer and its potential for preclinical trials.

  2007cited by this paper
• A protocol for isolation and culture of human umbilical vein endothelial cells

  2007cited by this paper
• Gene transfer approaches for gynecological diseases.

  2006cited by this paper
• Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives

  2005cited by this paper
• Polyethylenimine-based non-viral gene delivery systems.

  2005cited by this paper
• Endothelial monocyte activating polypeptide-II induced gene expression changes in endothelial cells.

  2005influential reference
• Early genetic mechanisms underlying the inhibitory effects of endostatin and fumagillin on human endothelial cells.

  2004cited by this paper
• Gene therapy clinical trials worldwide 1989–2004—an overview

  2004cited by this paper
• A polymer library approach to suicide gene therapy for cancer.

  2004cited by this paper
• Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine.

  2003cited by this paper
• Cationic lipid-DNA complexes-lipoplexes-for gene transfer and therapy.

  2002cited by this paper
• Novel Pathways Associated with Bypassing Cellular Senescence in Human Prostate Epithelial Cells* 210

  2002cited by this paper
• The promise and potential hazards of adenovirus gene therapy

  2001cited by this paper
• Molecular classification of human carcinomas by use of gene expression signatures.

  2001cited by this paper
• Systematic variation in gene expression patterns in human cancer cell lines

  2000cited by this paper
• A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells.

  1997cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

  1994cited by this paper

• An insight of nanogels as novel drug delivery system with potential hybrid nanogel applications

  2021cites this paper
• Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma

  2021cites this paper
• Nanotechnology advances in ovarian cancer

  2021cites this paper
• Advancement in the Biomedical Applications of the (Nano)gel Structures Based on Particular Polysaccharides.

  2019cites this paper
• Association of coding and UTR variants in the known regions with wet age-related macular degeneration in Han Chinese population

  2018cites this paper
• Enhanced antitumor effect of biodegradable cationic heparin-polyethyleneimine nanogels delivering FILIP1LΔC103 gene combined with low-dose cisplatin on ovarian cancer

  2017influential citation
• Filamin A interacting protein 1-like expression inhibits progression in colorectal cancer

  2016cites this paper
• Exploring the intraperitoneal route of administration for siRNA delivery in the treatment of pertitoneal carcinomatosis

  2016cites this paper
• Advanced nanocarriers based on heparin and its derivatives for cancer management.

  2015cites this paper
• Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels

  2015cites this paper
• Filamin A interacting protein 1-like as a therapeutic target in cancer

  2014cites this paper
• Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics.

  2014cites this paper
• Antitumor effects of heparin-polyethyleneimine nanogels delivering claudin-3-targeted short hairpin RNA combined with low-dose cisplatin on ovarian cancer.

  2014cites this paper
• Cationic polymer nanoparticles and nanogels: from synthesis to biotechnological applications.

  2014cites this paper
• Filamin A interacting protein 1‐like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis

  2014cites this paper
• Down-Regulation of Filamin Ainteracting protein 1-like Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers

  2013cites this paper
• Functional analysis of low-moderate risk susceptibility genes emerging from pathway based approaches and genome wide association studies in epithelial ovarian cancer

  2013cites this paper
• Intraperitoneal delivery of nanoparticles for cancer gene therapy.

  2013cites this paper
• Efficient inhibition of ovarian cancer by recombinant CXC chemokine ligand 10 delivered by novel biodegradable cationic heparin-polyethyleneimine nanogels.

  2012cites this paper